CutisPub Date : 2026-02-01DOI: 10.12788/cutis.1327
Dustine Reich, Shari R Lipner
{"title":"Waterproof Cast Protector Keeps Wound Dressing Intact Following Nail Surgery.","authors":"Dustine Reich, Shari R Lipner","doi":"10.12788/cutis.1327","DOIUrl":"https://doi.org/10.12788/cutis.1327","url":null,"abstract":"<p><p>A bulky dressing is applied following nail biopsy, and patients are instructed to keep it dry for 48 hours; however, this can be challenging, as the dressing can restrict bathing, washing dishes, and other daily tasks. We propose a solution using a removable waterproof arm cast protector that allows patients to continue their regular activities while keeping the dressing dry and intact to allow for optimal wound healing.</p>","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 2","pages":"58-68"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147626907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CutisPub Date : 2026-02-01DOI: 10.12788/cutis.1334
Nathaniel C Elston, Dirk M Elston
{"title":"Dermatologic Implications of Prickly Pear Cacti (Opuntia).","authors":"Nathaniel C Elston, Dirk M Elston","doi":"10.12788/cutis.1334","DOIUrl":"https://doi.org/10.12788/cutis.1334","url":null,"abstract":"<p><p>Prickly pear cacti spines that become embedded in the skin are associated with local and systemic inflammatory conditions as well as allergic contact dermatitis. Preclinical studies have suggested that extracts from the prickly pear cactus may be used in medicine due to their anti-inflammatory properties. This manuscript discusses complications and therapeutic possibilities related to the cacti.</p>","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 2","pages":"55-57"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147627466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CutisPub Date : 2026-02-01DOI: 10.12788/cutis.1333
Abizairie Sánchez-Feliciano, Sherry Ershadi, John S Barbieri
{"title":"Environmental and Lifestyle Triggers of Rosacea.","authors":"Abizairie Sánchez-Feliciano, Sherry Ershadi, John S Barbieri","doi":"10.12788/cutis.1333","DOIUrl":"https://doi.org/10.12788/cutis.1333","url":null,"abstract":"<p><p>Rosacea is a chronic inflammatory skin condition characterized by facial erythema, flushing, telangiectasias, papules, and pustules. Its pathophysiology involves a multifactorial interplay of genetic, immune, microbial, and neurovascular factors contributing to inflammation and vascular dysregulation. Environmental and lifestyle triggers are important contributors to disease exacerbation. In this review, we highlight 4 major modifiable triggers-UV radiation exposure, temperature fluctuation, skin care practices, and diet-and their roles in rosacea pathogenesis and management. Lifestyle modifications targeting these triggers combined with topical, oral, and/or laser therapies can improve disease control. A holistic, patient-specific approach to treatment that involves education on environmental influences and tailored management strategies is essential.</p>","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 2","pages":"65-68"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147626652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CutisPub Date : 2026-02-01DOI: 10.12788/cutis.1331
Haimeng Margaret Zhao, Willis H Lyford
{"title":"Screening for Meaning: Do Skin Cancer Screening Events Accomplish Anything?","authors":"Haimeng Margaret Zhao, Willis H Lyford","doi":"10.12788/cutis.1331","DOIUrl":"https://doi.org/10.12788/cutis.1331","url":null,"abstract":"","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 2","pages":"42-43"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147626932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nonhealing Lesion on the Ear in a Child.","authors":"Marisa Jinesh Patel, Melissa Rosenberg, Michelle Gallagher","doi":"10.12788/cutis.1330","DOIUrl":"https://doi.org/10.12788/cutis.1330","url":null,"abstract":"","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 2","pages":"44-50"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147626609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CutisPub Date : 2026-01-01DOI: 10.12788/cutis.1344
Maya K Hagander, Nicole L Edmonds, Bridget M Bryer
{"title":"Assessing Inpatient Dermatology Availability in Virginia.","authors":"Maya K Hagander, Nicole L Edmonds, Bridget M Bryer","doi":"10.12788/cutis.1344","DOIUrl":"https://doi.org/10.12788/cutis.1344","url":null,"abstract":"","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 1","pages":"E50-E51"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147466685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CutisPub Date : 2026-01-01DOI: 10.12788/cutis.1338
Ashley Lou Rensted, Alexander Hall, Joseph Giancola, Neel Patel
{"title":"Intralesional Methotrexate: A Cost-Effective, High-Efficacy Alternative to Surgery for Cutaneous Squamous Cell Carcinoma.","authors":"Ashley Lou Rensted, Alexander Hall, Joseph Giancola, Neel Patel","doi":"10.12788/cutis.1338","DOIUrl":"https://doi.org/10.12788/cutis.1338","url":null,"abstract":"<p><p>Squamous cell carcinoma (SCC) is the second most common type of skin cancer and often is treated surgically. Not all patients are surgical candidates, and sometimes the cost of Mohs micrographic surgery or wide local excision is a barrier for patients. In this study, we explored the use of intralesional methotrexate (IL-MTX) as a treatment for SCC. Our results demonstrate that treatment with IL-MTX could be an excellent option for patients who cannot be treated surgically. However, more research is needed to characterize which lesions are the best candidates for IL-MTX therapy.</p>","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 1","pages":"E29-E32"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147467104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CutisPub Date : 2026-01-01DOI: 10.12788/cutis.1301
Jerry Bagel, Alexa Hetzel, Ashley Reed, Elise Nelson
{"title":"Safety and Effectiveness of Nonsteroidal Tapinarof Cream 1% Added to Ongoing Biologic Therapy for Treatment of Moderate to Severe Plaque Psoriasis.","authors":"Jerry Bagel, Alexa Hetzel, Ashley Reed, Elise Nelson","doi":"10.12788/cutis.1301","DOIUrl":"https://doi.org/10.12788/cutis.1301","url":null,"abstract":"<p><p>The aim of this prospective, open-label, single-center study was to evaluate the effectiveness and safety of nonsteroidal tapinarof cream 1% added to ongoing biologic therapy in patients with plaque psoriasis who did not adequately respond to a biologic alone. Males and females aged 18 years and older with moderate to severe plaque psoriasis (≥3% body surface area [BSA] involvement) who had been receiving a biologic for 24 weeks or more applied tapinarof cream 1% once daily for 12 weeks. Patients were followed an additional 4 weeks after treatment discontinuation through week 16 to assess for a remittive (maintenance) effect. The primary end point was the proportion of patients achieving the National Psoriasis Foundation's treat-to-target (TTT) goal of 1% or less BSA involvement at week 12. Of the 30 patients enrolled (mean age, 55.4 years; 66.7% [20/30] male), 20 completed the study. The proportion of patients reaching the TTT goal increased over time to 52.4% (11/21) at week 12 and 40% (8/20) at week 16. Mean percentage of BSA involvement and physician's global assessment (PGA) score, composite PGA multiplied by mean percentage of BSA involvement (PGA×BSA), and psoriasis area severity index (PASI) scores also improved with tapinarof cream added to biologic therapy up to week 12 and were maintained until week 16. Few adverse events (AEs), no serious AEs, and no AE-related discontinuations were reported. In conclusion, adding nonsteroidal tapinarof cream to an ongoing biologic was tolerable in our study population and potentially can help patients achieve the TTT goal, preserving safety and cost associated with their current biologic therapy.</p>","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 1","pages":"16-25"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147467192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CutisPub Date : 2026-01-01DOI: 10.12788/cutis.1313
Lorraine L Rosamilia
{"title":"Antibiotic Stewardship in Acne: Practical Tips From Dr. Lorraine L. Rosamilia.","authors":"Lorraine L Rosamilia","doi":"10.12788/cutis.1313","DOIUrl":"https://doi.org/10.12788/cutis.1313","url":null,"abstract":"","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"117 1","pages":"30-31"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147466777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}